10x Genomics Earnings
NASDAQ: TXGIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.27
10x Genomics earnings summary
10x Genomics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.27. In its most recent report on Aug 7, 2026 (Q2 2026), TXG posted EPS of $-0.14. Revenue for the quarter was $151.0 million.
Quarterly EPS is down 150.0% from the same quarter a year earlier. Across the last 16 reports, TXG shares moved an average of 8.1% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.
Summary generated from market data by MetaCap's automated system. Methodology
TXG earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 7, 2026 | — | $-0.14 | — | +7.8% |
| May 8, 2026 | — | $-0.10 | — | -1.9% |
| Feb 13, 2026 | — | $-0.13 | — | +4.2% |
| Nov 7, 2025 | — | $-0.22 | — | +4.2% |
| Aug 8, 2025 | — | $0.28 | — | +8.7% |
| May 9, 2025 | — | $-0.28 | — | +7.1% |
| Feb 13, 2025 | — | $-0.40 | — | -11.5% |
| Oct 29, 2024 | — | $-0.30 | — | -4.2% |
| Aug 8, 2024 | — | $-0.32 | — | +6.5% |
| Apr 30, 2024 | — | $-0.50 | — | -5.4% |
| Feb 15, 2024 | — | $-0.42 | — | -7.2% |
| Nov 3, 2023 | — | $-0.79 | — | -10.7% |
| Aug 4, 2023 | — | $-0.53 | — | -9.7% |
| May 4, 2023 | — | $-0.44 | — | -3.0% |
| Feb 16, 2023 | — | $-0.14 | — | -8.8% |
| Nov 3, 2022 | — | $-0.37 | — | +29.4% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.